July 8, 2016July 8, 2016

Actelion Begins Phase 3 Study of Opsumit as Possible Treatment for Children with PAH

Actelion announced the launch of a Phase 3 clinical trial evaluating the effectiveness of a pediatric formulation of Opsumit (macitentan) in delaying disease progression in children with pulmonary arterial hypertension (PAH). Opsumit is an orally available ... Read more

January 6, 2016January 6, 2016

Sildenafil as PAH Therapy for Children in Need of Further Study

News, Pulmonary Hypertension

A group of researchers reviewed the results from two clinical trials, STARTS-I and STARTS-II, testing the use of sildenafil as a therapy for children with pulmonary arterial hypertension (PAH), and ... Read more